A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit.
Force feeding, unnecessary x-rays, misusing health information, and discharging unstable patients are classic dual-loyalty dilemmas reminiscent of the Holocaust.
AMA J Ethics. 2021;23(1):E38-45. doi:
10.1001/amajethics.2021.38.